This Article Full Text Full Text (PDF) All Versions of this Article: 120/4/275    most recent CIRCULATIONAHA.109.879957v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Google Scholar Articles by Maurer, G. PubMed PubMed Citation Articles by Maurer, G. Related Collections Congestive Animal models of human disease Valvular heart disease Echocardiography CV surgery: valvular disease Cardiac development Other Vascular biology Related Article

(Circulation. 2009;120:275-277.)
© 2009 American Heart Association, Inc.

Editorial

Mitral Leaflet in Functional Regurgitation

Passive Bystander or Active Player?

Gerald Maurer, MD

From the Division of Cardiology, Medical University of Vienna, Vienna, Austria.

Correspondence to Gerald Maurer, MD, Division of Cardiology, Medical University of Vienna, Waehringer Guertel 18–20, 1090 Vienna, Austria. E-mail gerald.maurer@meduniwien.ac.at

Key Words: Editorials • cardiomyopathy • growth substances • ischemia • remodeling • mitral valve

An extract of the first 250 words of the full text is provided, because this article has no abstract.

	Introduction

 
In a population-based study, mitral regurgitation (MR) has been found to be the most common form of valvular heart disease in the United States.¹ The incidence of MR rises sharply at 65 years of age: moderate or severe MR is estimated to occur in 1% of the 55 to 64 age group, increasing to 6.4% for individuals aged 65 to 74 and to 9.3% for those older than 75.¹ In view of the increasing life expectancy of the general population, we can anticipate encountering a substantial rise in the number of patients with hemodynamically significant MR. Because heart failure, ischemic heart disease, and other disorders affecting the left ventricle become more prevalent with older age, one can speculate that it is particularly functional MR that will contribute to the overall increase in MR cases, with the numbers caused by degenerative disease rising less dramatically with age.

Article see p 334

As the rate of rheumatic disease has decreased dramatically in the Western world, degenerative disease, largely resulting from myxomatous degeneration, constitutes the most common reason for mitral valve surgery. The true incidence of functional MR, in which the primary cause of regurgitation does not originate from the leaflets themselves, is not well known. Many patients with functional MR never undergo surgery, and the disease can remain silent for some time or can be masked by the underlying pathology of the left ventricle and the coronary arteries.

Functional MR is an entity that was poorly understood until some years ago. Whereas . . . [Full Text of this Article]

Related Article:

Active Adaptation of the Tethered Mitral Valve: Insights Into a Compensatory Mechanism for Functional Mitral Regurgitation

Jacob P. Dal-Bianco, Elena Aikawa, Joyce Bischoff, J. Luis Guerrero, Mark D. Handschumacher, Suzanne Sullivan, Benjamin Johnson, James S. Titus, Yoshiko Iwamoto, Jill Wylie-Sears, Robert A. Levine, and Alain Carpentier
Circulation 2009 120: 334-342. [Abstract] [Full Text]